{"paper_id":"a5189c58-2f61-443e-82cc-52cf52376a89","body_text":"Zusammenfassung\nDie Endometriose zählt zu den häufigsten, jedoch oft erst spät diagnostizierten Erkrankungen der Frau und kann die Fertilität signifikant beeinträchtigen, was wiederum Auswirkungen auf die Familienplanung der Betroffenen hat. Die in Kürze verfügbare aktualisierte S2k-Leitlinie zur Diagnostik und Therapie der Endometriose beinhaltet umfassende Neuerungen, insbesondere im Kapitel zum Vorgehen bei Kinderwunsch. Dieses wurde erheblich erweitert und um wichtige Themen, wie den Einsatz medizinisch assistierter Reproduktionsverfahren, den Einfluss der Erkrankung auf die ovarielle Reserve und die Fertilitätsprotektion, ergänzt. Diese Aktualisierungen ermöglichen es Patientinnen und ihren Behandlern, auf die neuesten Informationen für Diagnostik und Therapie zurückzugreifen.\nAbstract\nEndometriosis is among the most common conditions in women but is often diagnosed late and can significantly impair fertility, which in turn affects the family planning of those affected. The soon to be released updated S2k guidelines for the diagnostics and treatment of endometriosis includes comprehensive updates, particularly in the chapter on management of patients with a desire to have children. This has been significantly expanded to include important topics, such as the use of medically assisted reproductive techniques, the impact of the disease on the ovarian reserve and fertility preservation. These updates enable patients and healthcare providers to access and use the latest information on diagnostics and treatment.\nSimilar content being viewed by others\nLiteratur\nAlborzi S, Zahiri Sorouri Z, Askari E et al (2019) The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies. Reprod Med Biol 18:312–322\nAnderson RA, Amant F, Braat D et al (2020) ESHRE guideline: female fertility preservation. Hum Reprod Open 2020:hoaa52\nAwmf (2019) Diagnostic and therapy before assisted reproductive treatments, Guideline of the DGGG, OEGGG, SGGG (S2k-Level, AWMF Registry No. 015/085, 02/2019)\nBafort C, Beebeejaun Y, Tomassetti C et al (2020) Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 10:CD11031\nBecker CM, Bokor A, Heikinheimo O et al (2022) ESHRE guideline: endometriosis. Hum Reprod Open 2022:hoac9\nBuggio L, Monti E, Gattei U et al (2018) Adenomyosis: fertility and obstetric outcome. A comprehensive literature review. Minerva Ginecol 70:295–302\nBundesamt S (2022) Daten zum durchschnittlichen Alter der Eltern bei Geburt. https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Geburten/Tabellen/geburten-eltern-biologischesalter.html\nBundesärztekammer (2022) Richtlinie zur Entnahme und Übertragung von menschlichen Keimzellen oder Keimzellgewebe im Rahmen der assistierten Reproduktion, umschriebene Fortschreibung 2022. Dtsch Ärztebl. https://doi.org/10.3238/arztebl.2022.Rili_assReproduktion_2022\nBundesausschuss G (2022) Beschluss, Richtlinie zur Kryokonservierung von Ei- oder Samenzellen oder Keimzellgewebe sowie entsprechende medizinische Maßnahmen wegen keimzellschädigender Therapie (Kryo-RL). BAnz AT 14.11.2022 B2\nCasals G, Carrera M, Domínguez JA et al (2021) Impact of Surgery for Deep Infiltrative Endometriosis before In Vitro Fertilization: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol 28:1303–1312.e1305\nChang HJ, Han SH, Lee JR et al (2010) Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels. Fertil Steril 94:343–349\nChang Y, Shen M, Wang S et al (2022) Association of embryo transfer type with infertility in endometriosis: a systematic review and meta-analysis. J Assist Reprod Genet 39:1033–1043\nChen I, Veth VB, Choudhry AJ et al (2020) Pre- and postsurgical medical therapy for endometriosis surgery. Cochrane Database Syst Rev 11:CD3678\nCobo A, Coello A, De Los Santos MJ et al (2021) Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis. Reprod Biomed Online 42:725–732\nCobo A, Giles J, Paolelli S et al (2020) Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril 113:836–844\nCozzolino M, Tartaglia S, Pellegrini L et al (2022) The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis. Reprod Sci 29:3177–3193\nDiaz-Garcia C, Domingo J, Garcia-Velasco JA et al (2018) Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril 109:478–485.e472\nDongye H, Ji X, Ma X et al (2021) The Impact of Endometriosis on Embryo Quality in in-vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis. Front Med 8:669342\nHeng FW, Shorey S (2022) Experiences of endometriosis-associated infertility among women and their partners: A qualitative systematic review. J Clin Nurs 31:2706–2715\nHirokawa W, Iwase A, Goto M et al (2011) The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 26:904–910\nHodgson RM, Lee HL, Wang R et al (2020) Interventions for endometriosis-related infertility: a systematic review and network meta-analysis. Fertil Steril 113:374–382 e372\nHughes E, Brown J, Collins JJ et al (2007) Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007:CD155\nHwu YM, Wu FS, Li SH et al (2011) The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels. Reprod Biol Endocrinol 9:80\nIwase A, Hirokawa W, Goto M et al (2010) Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil Steril 94:2846–2849\nJohnson NP, Hummelshoj L, World Endometriosis Society Montpellier C (2013) Consensus on current management of endometriosis. Hum Reprod 28:1552–1568\nKalampokas T, Kamath MS, Kalampokas E (2013) AMH after laparoscopic surgery of the ovaries: a review. Gynecol Endocrinol 29:408–411\nKaponis A, Chatzopoulos G, Paschopoulos M et al (2020) Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial. Fertil Steril 113:828–835\nKuan KKW, Omoseni S, Tello JA (2023) Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review. Ther Adv Endocrinol Metab 14:20420188231173325\nLeyendecker G, Kunz G, Wildt L et al (1996) Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 11:1542–1551\nLiu S, Xie Y, Li F et al (2021) Effectiveness of ultra-long protocol on in vitro fertilization/intracytoplasmic sperm injection-embryo transfer outcome in infertile women with endometriosis: A systematic review and meta-analysis of randomized controlled trials. J Obstet Gynaecol Res 47:1232–1242\nLiu Y, Gong H, Gou J et al (2021) Dienogest as a Maintenance Treatment for Endometriosis Following Surgery: A Systematic Review and Meta-Analysis. Front Med 8:652505\nMacer ML, Taylor HS (2012) Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 39:535–549\nMoreno-Sepulveda J, Romeral C, Niño G et al (2022) The Effect of Laparoscopic Endometrioma Surgery on Anti-Müllerian Hormone: A Systematic Review of the Literature and Meta-Analysis. JBRA Assist Reprod 26:88–104\nNankali A, Kazeminia M, Jamshidi PK et al (2020) The effect of unilateral and bilateral laparoscopic surgery for endometriosis on Anti-Mullerian Hormone (AMH) level after 3 and 6 months: a systematic review and meta-analysis. Health Qual Life Outcomes 18:314\nNulsen JC, Walsh S, Dumez S et al (1993) A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol 82:780–786\nPluchino N, Wenger JM, Petignat P et al (2016) Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment. Hum Reprod Update 22:762–774\nPractice Committee of the American Society for Reproductive M (2012) Endometriosis and infertility: a committee opinion. Fertil Steril 98:591–598\nRangi S, Hur C, Richards E et al (2023) Fertility Preservation in Women with Endometriosis. J Clin Med 12(13):4331\nRizzello F, Coccia ME (2018) Direct shedding of endometrioma contents through the follicle rupture: Insight on the pathogenesis of endometriosis. Eur J Obstet Gynecol Reprod Biol 223:144–145\nRodríguez-Tárrega E, Monzo AM, Quiroga R et al (2020) Effect of GnRH agonist before IVF on outcomes in infertile endometriosis patients: a randomized controlled trial. Reprod Biomed Online 41:653–662\nSantulli P, Bourdon M, Koutchinsky S et al (2021) Fertility preservation for patients affected by endometriosis should ideally be carried out before surgery. Reprod Biomed Online 43:853–863\nSomigliana E, Viganò P, Benaglia L et al (2019) Ovarian stimulation and endometriosis progression or recurrence: a systematic review. Reprod Biomed Online 38:185–194\nTal R, Seifer DB (2017) Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol 217:129–140\nTummon IS, Asher LJ, Martin JS et al (1997) Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril 68:8–12\nVan Der Houwen LE, Schreurs AM, Schats R et al (2014) Efficacy and safety of intrauterine insemination in patients with moderate-to-severe endometriosis. Reprod Biomed Online 28:590–598\nYounis JS, Shapso N, Ben-Sira Y et al (2022) Endometrioma surgery‑a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am J Obstet Gynecol 226:33–51.e37\nDanksagung\nDie Überarbeitung der S2k-Leitlinie ist nur durch Engagement vieler mit dem Thema vertrauter Personen möglich. Am Kapitel zum Kinderwunsch bei Endometriose haben u. a. folgende Personen mitgewirkt und dieses durch ihren Beitrag erheblich verbessert und erweitert: Prof. Karl-Jürgen Bär, Dr. Julia Bartley, Prof. Beate Ditzen, Prof. Ricardo E. Felberbaum, Prof. Katharina Hancke, Prof. Sylvia Mechsner, Prof. Nicole Sänger, Dr. Sebastian Schäfer, Prof. Tewes Wischmann, PD Dr. Monika Wölfler.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEthics declarations\nInteressenkonflikt\nF. von Versen-Höynck gibt an, dass kein Interessenkonflikt besteht.\nFür diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.\nAdditional information\nRedaktion\nKlaus Diedrich, Lübeck\nRicardo Felberbaum, Kempten\nKatharina Hancke, Ulm\nWolfgang Küpker, Baden-Baden\nThomas Strowitzki, Heidelberg\nHinweis des Verlags\nDer Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.\nQR-Code scannen & Beitrag online lesen\nRights and permissions\nAbout this article\nCite this article\nvon Versen-Höynck, F. Aktualisierung der Endometriose-Leitlinie. Gynäkologie 57, 693–697 (2024). https://doi.org/10.1007/s00129-024-05282-2\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00129-024-05282-2","source_license":"CC0","license_restricted":false}